Johnson & Johnson's FcRn inhibitor nipocalimab has been awarded fast-track status by the FDA as a treatment for Sjogren's ...

An even greater challenge is their need for external investment. During the early stages of development, in order to progress ...

The tragic death of the 16-year-old boy came as a result of acute liver failure, which is a known side effect of Elevidys and ...

The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to ...

Coined by industry as the only meeting of its kind, uniquely positioned to share fresh ideas and assess viable approaches to ...

Novartis said that the latest round of job losses is a result of a change in focus for its cardiovascular teams as they lower the emphasis on Entresto and devote more resources to its twice-yearly ...

February saw a flurry of significant hires in the agency world, with several key players making strategic appointments to bolster their leadership teams. We’ve also included consultancy and investor ...

EnteroBiotix's IBS trial is the company's second to suggest there is value in the approach, coming a few months after the ...

Central rebates amounted to £631 million in England in 2023/24. This explains the headline stat of a £19.9bn spend on ...

Novo Nordisk became only the eighth company to be suspended from the ABPI in its 40-year history for several transgressions, the most serious of which was a breach of Clause 2 of the code, deemed to ...

By identifying friction points and translating them into actionable insights, CX teams help ensure innovation is grounded in real user needs, rather than assumptions. They prevent businesses from ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging ...